Navalign LLC’s HCA Healthcare HCA Stock Holding History

Navalign LLC’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$10K	–	271
2025 Q4	$10K	Buy	+21	New	+$9.75K	﹤0.01%	335

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Navalign LLC's HCA Position: Q1 2026 in Review

Navalign LLC sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 21 shares — an estimated $10K sold.

Navalign LLC first reported a position in HCA in Q4 2025 and held it in 1 quarter. The position peaked at $10K in Q4 2025. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

Navalign LLC reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 21 HCA Healthcare shares in Q1 2026, an estimated $10K.
Navalign LLC first reported a position in HCA Healthcare in Q4 2025 and held it in 1 quarter.
Navalign LLC's HCA Healthcare position peaked at $10K in Q4 2025.
1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.